Regard
AI clinical insights platform that surfaces patient history context and documentation before physician review.
Last updated: June 5, 2026
Back to directoryPrior authorization AI from Apixio/Datavant that uses historical administrative and decision data to support automated approvals and reviewer routing.
Payer teams trying to reduce manual prior authorization review volume while preserving policy controls, clinical-review queues, and auditability.
Compare within workflow: Clinical operations and revenue cycle · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Apicare AuthAdvisor as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as high-risk payer utilization-management decision support because it can affect access to care; verify current CMS, state, accreditation, medical-policy, appeal, and adverse-determination requirements before automating any decision path. |
|---|---|
| Privacy | Review BAA terms, Datavant/Apixio contracting entity, PHI and administrative-data feeds, historical decision-data use, model-training boundaries, role-based access, audit logs, retention, and subcontractors. |
| Evidence | Require local validation for auto-approval precision, reviewer workload, overturned decisions, appeal rates, service-line performance, subgroup impact, and whether thresholds drift after policy or network changes. |
| Workflow | Best governed as payer prior authorization routing and approval support with configurable thresholds, clinical reviewer oversight, policy-change controls, denial safeguards, appeal monitoring, and provider/member communication checks. |
Apixio materials describe Apicare AuthAdvisor as AI-powered prior authorization decision support that analyzes historical administrative and decision data, can approve requests in seconds, exposes user-controlled thresholds by procedure, and routes requests needing review; Datavant privacy materials describe HIPAA business-associate safeguards for PHI handled on behalf of healthcare customers, while CMS prior authorization rules frame payer obligations for interoperability, decision data, and process transparency.
Not for: Provider-side prior authorization submission, autonomous denial without clinical oversight, emergency-care triage, or use without policy, appeal, and bias monitoring.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.